发明名称 COMPOSITION AND METHOD FOR ADMINISTERING TUBULIN BINDING AGENT FOR TREATMENT OF OCULAR DISEASE
摘要 <P>PROBLEM TO BE SOLVED: To provide a method of administering vascular targeting agents (particularly a tubulin binding agent) for treating malignant or nonmalignant vascular proliferative diseases in ocular tissues. <P>SOLUTION: The invention relates to administration of vascular targeting agents, particularly the tubulin binding agent, for treating ocular neovascularization, ocular tumors, and conditions such as diabetic retinopathy, retinopathy of premature baby, retinoblastoma and macular degeneration. The method provided for treating ocular diseases involves the following processes: (a) a process of preparing medication including a pharmacologically effective dosage of the tubulin binding agent and (b) a process of administering the pharmacologically effective dosage to a subject requiring the treatment. <P>COPYRIGHT: (C)2009,JPO&INPIT
申请公布号 JP2009132738(A) 申请公布日期 2009.06.18
申请号 JP20090063664 申请日期 2009.03.16
申请人 OXIGENE INC 发明人 SHERRIS DAVID;WOOD MARK
分类号 A61K9/06;A61K45/00;A61K9/08;A61K31/09;A61K31/135;A61K36/18;A61P3/10;A61P9/00;A61P9/10;A61P17/02;A61P27/02;A61P31/04;A61P31/12;A61P35/00;A61P43/00 主分类号 A61K9/06
代理机构 代理人
主权项
地址